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Introduction
Mitosis in most animal cells is thought to be triggered by the 
activation of the cyclin B1–associated kinase, Cdk1 (for review 
see Lindqvist et al., 2009). Once activated, cyclin B1–Cdk1 
can  phosphorylate  a  plethora  of  substrates,  thereby  promot­
ing the substantial reorganization of the cell architecture upon 
which mitosis and cytokinesis depend. These substrates are 
both nuclear and cytoplasmic, including components of the cyto­
skeleton microtubule (Andersen et al., 1997; Vasquez et al., 
1999; Liakopoulos et al., 2003; Moore and Miller, 2007), actin   
(Yamashiro et al., 1991; Yamashiro et al., 2001) and inter­
mediate filament networks (Chou et al., 1990; Yamaguchi et al., 
2005), caspases (Allan and Clarke, 2007), the Golgi apparatus 
(Lowe et al., 1998; Draviam et al., 2001; Wang et al., 2003; 
Preisinger  et  al.,  2005),  the  nucleolus  (Peter  et  al.,  1990a; 
Klein and Grummt, 1999; Sirri et al., 2002), nuclear lamins 
(Peter et al., 1990b; Lüscher et al., 1991), nuclear pore com­
plexes (Onischenko et al., 2005; Lusk et al., 2007; for review   
see Kutay and Hetzer, 2008), and the anaphase­promoting complex/ 
cyclosome (the E3 ligase that eventually degrades cyclin B1 in 
mitosis; Rudner and Murray, 2000; Kraft et al., 2003). Thus, 
Cdk1 has been described as the workhorse of the mitotic cell 
(Nigg, 1991). These substrates are crucial to the generation of 
the mitotic spindle, chromosome condensation, and nuclear 
envelope breakdown (NEBD) that characterize mitosis in most 
animal cells. Yet, despite its importance, the means by which 
cyclin B1–Cdk1 coordinates the dramatic changes in the nucleus 
and the cytoplasm remains unknown.
One mechanism that is likely to be important to co­
ordinate entry to mitosis is that cyclin B1–Cdk1 is rapidly im­
ported into the nucleus just before NEBD (Pines and Hunter, 
1991; Ookata et al., 1992), but how this is triggered and how 
it relates to the activation of cyclin B1–Cdk1 is unknown. In 
interphase, cyclin B1 shuttles between the nucleus and the 
cytoplasm but is mostly cytoplasmic because its rate of nu­
clear export exceeds its rate of import (Hagting et al., 1998; 
Toyoshima et al., 1998; Yang et al., 1998). The nuclear export 
sequence (NES) binds to the exportin Crm1 (Yang et al., 1998) 
and is located in the N terminus of cyclin B1, where it is sur­
rounded by phosphorylation sites, including sites for the Plk1 
kinase,  either  in  the  NES  on  Ser147  (Toyoshima­Morimoto 
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is specifically phosphorylated by cyclin B1–Cdk1 and not by   
cyclin A– or cyclin E–Cdk complexes, and upon phosphorylation, 
exhibits  an  increase  in  Förster  resonance  energy  transfer 
(FRET) between its constituent cyan and yellow fluorescent 
proteins. With this biosensor, we found that cyclin B1–Cdk1 
was activated 27 min before NEBD in HeLa and 18 min 
before  NEBD  in  retinal  pigment  epithelial  cells.  In  both 
cell  types,  activation  was  immediately  followed  by  centro­
some separation and cell rounding (Gavet and Pines, 2010). 
Because cyclin B1 accumulated in the nucleus before NEBD, 
we investigated the relation between cyclin B1–Cdk1 activation 
and its nuclear transport in prophase. Using HeLa cells ex­
pressing the cyclin B1–Cdk1 biosensor and a fluorescently 
tagged cyclin B1, cyclin B1–mCherry, we found an excellent 
correlation between the initial activation of cyclin B1–Cdk1 
and its rapid nuclear import (Fig. 1 and Video 1). Cyclin B1   
began  to  accumulate  in  the  nucleus  an  average  of  30  s 
after the FRET signal began to increase (27 ± 7 min before 
NEBD; n = 18). This result indicated that cyclin B1–Cdk1 
activation might trigger its nuclear accumulation; therefore, 
to test this hypothesis, we simultaneously recorded the FRET   
ratio and the nuclear accumulation of cyclin B1 in early pro­
phase and added a potent Cdk1 inhibitor (Cdk1/2 inhibitor III)   
a few minutes after cyclin B1 began to move into the nucleus. 
We observed an immediate reduction in cyclin B1 import rate 
followed by its export from the nucleus (Fig. 2 A and Video 2).   
Correlating  this  with  cyclin  B1–Cdk1  activity showed that 
the FRET signal started to decrease 0.5–1 min after adding the 
drug and was closely followed by the nuclear export of cy­
clin B1 1–2 min later (n = 6). Adding the inhibitor even 
in late prophase triggered cyclin B1 export and completely 
inhibited NEBD and entry to mitosis. We also observed that 
the total level of cyclin B1–mCherry fluorescence started to 
decrease 9–10 min after adding the Cdk inhibitor, most 
likely as a consequence of activating the anaphase­promoting 
complex/cyclosome (Di Fiore and Pines, 2008). Identical re­
sults  were  obtained  using  another  Cdk  inhibitor  (RO3306; 
unpublished data). As a control, we tested the effect of add­
ing an aurora B inhibitor (ZM447439), and this had no effect 
on the nuclear accumulation of cyclin B1 (Fig. 2 B). Thus, 
we conclude that cyclin B1–Cdk1 activation triggers its own 
nuclear import in prophase.
Cyclin B1–Cdk1 is active in both the 
nucleus and the cytoplasm in prophase
Because  activating  cyclin  B1–Cdk1  immediately  triggered 
its import into the nucleus, it was possible that this would 
deplete  active  cyclin  B1–Cdk1  from  the  cytoplasm  until 
NEBD. To test this, we compared the activation of cyclin B1– 
Cdk1 in the cytoplasm and the nucleus using modified ver­
sions  of  the  cyclin  B1–Cdk1  biosensor.  We  targeted  the 
biosensor to the cytoplasm by tagging it with an NES and 
targeted it to chromosomes by fusing it with histone H2B 
(Fig. S1 A). Fluorescence loss in photobleaching and FRAP 
assays  confirmed  that  the  H2B  fusion  protein  was  stably   
attached to chromosomes and did not diffuse into the cyto­
plasm (Fig. S1 B and not depicted). Monitoring dividing cells 
et al., 2001) or nearby on Ser133 (Hagting et al., 1999; Yuan 
et al., 2002; Jackman et al., 2003). Substituting the Ser in the 
NES with glutamic acid reduces cyclin B1 nuclear export in 
Xenopus laevis oocytes and impairs its ability to bind to Crm1 
in vitro (Yang et al., 2001). Thus, the prevailing view is that the 
sudden nuclear accumulation of cyclin B1 is caused by Plk1 
phosphorylating cyclin B1 at Ser147 in the NES and inhibiting 
its export (Toyoshima­Morimoto et al., 2001). This implicates 
Plk1 as the key regulator to coordinate the reorganization of the 
nucleus and the cytoplasm at mitosis. However, in conflict with 
this, we and others have shown that Plk1 phosphorylates cyclin B1 
on Ser133 not Ser147 (Yuan et al., 2002; Jackman et al., 2003) 
and that overexpressing Plk1 does not cause cyclin B1 to move 
into the nucleus in interphase (Jackman et al., 2003). Similarly, 
Lénárt et al. (2007) found that a Plk1 inhibitor did not block 
the nuclear import of cyclin B1 at mitosis.
We previously showed that cyclin B1–Cdk1 autophosphory­
lates two sites in its own N terminus (Ser126 and 128) that could 
be detected first at centrosomes, indicating that cyclin B1–Cdk1 
is activated in the cytoplasm (Jackman et al., 2003). Mutating 
all of these phosphorylation sites and both putative Plk1 phos­
phorylation sites in the N terminus to glutamic acid enhanced 
the nuclear import of cyclin B1–GFP in vitro and in interphase 
cells (Hagting et al., 1999; Yang et al., 2001), whereas mutat­
ing them to Ala appeared to delay the timing of cyclin B1 import 
in prophase. Thus, we suggested that the rapid accumulation of 
cyclin B1 into the nucleus at prophase was caused by a phos­
phorylation­dependent nuclear import signal in its N terminus 
triggered by a combination of cyclin B1–Cdk1 and Plk1 kinase 
activities (Hagting et al., 1999), but the temporal relationship 
between the activation of cyclin B1–Cdk1 and its nuclear import, 
and the role of Plk1 and the inhibition of nuclear export re­
mained unresolved.
We have recently developed a biosensor that can be used 
to  measure  specifically  cyclin  B1–Cdk1  activity  in  living 
cells. In this study, we use this probe to show that as soon as 
cyclin B1–Cdk1 is activated, it rapidly accumulates in the nu­
cleus, and this import depends on continual cyclin B1–Cdk1 
activity but is independent of the Plk1 kinase. Furthermore, we 
show that the change in cyclin B1 localization is generated 
almost exclusively by a strong increase in import rate through 
a general change in nuclear import machinery and not through 
generating a nuclear import signal on cyclin B1. Furthermore, we 
show that a substantial amount of cyclin B1–Cdk1 remains in 
the cytoplasm even at the peak of its nuclear accumulation just 
before NEBD. Thus, through the coupling of cyclin B1–Cdk1 
activity to its nuclear import, we strengthen the evidence that 
cyclin B1–Cdk1 must be activated in the cytoplasm and pro­
vide an elegantly simple molecular mechanism for how nuclear 
and cytoplasmic events are coordinated at the entry to mitosis.
Results
Cyclin B1–Cdk1 activity drives its  
nuclear import
We recently developed a biosensor to detect cyclin B1–Cdk1 
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(2007),  who  found  by  immunofluorescence  analysis  that 
some  active  cyclin  B1–Cdk1  remains  in  the  cytoplasm  in 
prophase,  whereas  the  rest  moves  into  the  nucleus.  Thus, 
activation  in  the  cytoplasm  allied  with  the  immediate  and 
rapid nuclear import of a proportion of cyclin B1–Cdk1 in­
herently synchronizes mitotic events in the cytoplasm and   
the nucleus.
by time­lapse microscopy showed that the change in FRET 
efficiency  of  the  biosensor  was  very  similar  between  the   
cytoplasm and the nucleus in all cells analyzed, indicating 
that  cyclin  B1–Cdk1  became  progressively  more  active  in 
both the cytoplasm and the nucleus as cells entered mitosis   
(n = 16 for three independent experiments; Fig. 3 and Video 3). 
These results agree with the conclusions of Lindqvist et al. 
Figure 1.  Activation and nuclear accumulation of cyclin B1–Cdk1 are coincident. (A) HeLa cells coexpressing the cyclin B1–Cdk1 activity FRET sensor 
and cyclin B1–mCherry were recorded at one image every 1 min 40 s by time-lapse fluorescence and differential interference contrast (DIC) microscopy 
as cells entered mitosis. Two cells entering mitosis are displayed for DIC (top), FRET efficiency determined by emission ratio (middle), and cyclin B1–
mCherry (bottom). Bars, 10 µm. (B) Quantification of the nuclear accumulation of cyclin B1 and emission ratio in three different cells. The vertical dashed 
line indicates when signals started to increase.JCB • VOLUME 189 • NUMBER 2 • 2010   250
Figure 2.  Nuclear accumulation of cyclin B1–Cdk1 depends on Cdk activity. (A) HeLa cells coexpressing the cyclin B1–Cdk1 activity FRET sensor and 
cyclin B1–mCherry were recorded at one image every 2 min as cells entered mitosis. After cyclin B1 began to move into the nucleus, 300 nM Cdk1/2 
inhibitor III was added. The quantification curves correspond to the cell displayed. Note the immediate decrease in the nuclear accumulation rate of 
cyclin B1 just after addition of the Cdk inhibitor before its reexport 3 min later. (B) Cells analyzed as in A were treated with 5 µM aurora B inhibitor 
ZM447439 in late G2 phase (n = 6). Bars, 10 µm.251 Cyclin B1–Cdk1 synchronizes the nucleus and the cytoplasm • Gavet and Pines
to EGFP was indistinguishable in timing or rate from wild­type 
cyclin B1–mCherry (Fig. 4 A, Fig. S3, and Video 4). Thus, 
neither autophosphorylation nor phosphorylation by Plk1 was 
required to trigger the nuclear accumulation of cyclin B1 in 
prophase. However, it was possible that Plk1 could trigger the 
nuclear accumulation of cyclin B1 by a mechanism separate 
from phosphorylating cyclin B1. Therefore, we tested the con­
sequence of adding a potent Plk1 inhibitor (BI 2536) to cells in 
prophase. As shown in Fig. 4 B, inhibiting Plk1 had no effect   
on the nuclear accumulation of cyclin B1 (Fig. 4 B and Video 5), 
which is in agreement with a previous study (Lénárt et al., 
2007). The potency of the inhibitor was confirmed because all 
cells were subsequently blocked in prometaphase after NEBD 
(Lénárt et al., 2007), and those cells in anaphase immediately 
failed cytokinesis when the inhibitor was added (Video 5; 
Burkard et al., 2007; Petronczki et al., 2007). Thus, we can 
conclude that Plk1 is not required to activate cyclin B1–Cdk1, 
for the nuclear import of cyclin B1, nor for the synchrony of 
nuclear and cytoplasmic changes in prophase.
Previously, we and others have shown that substituting 
glutamic acids at the phosphorylation sites in the N terminus 
of cyclin B1 created a nuclear import signal and reduced the 
binding between cyclin B1 and the exportin Crm1 in vitro 
Cyclin B1–Cdk1 accumulation in the 
nucleus does not require Plk1 activity  
or phosphorylation on cyclin B1
The coupling between cyclin B1–Cdk1 activation and its rapid 
import into the nucleus appeared to be the key to synchroniz­
ing  nuclear  and  cytoplasmic  changes  in  cell  architecture  as 
cells entered mitosis, but the mechanism behind this was un­
clear. Our previous results indicated that it was caused by an 
increase  in  nuclear  import  generated  by  phosphorylation  of 
the N terminus of cyclin B1 (Hagting et al., 1999), but other   
studies had concluded that phosphorylation, particularly phos­
phorylation by Plk1, inhibited the export of cyclin B1 (Yang et al., 
1998; Toyoshima­Morimoto et al., 2001).
To establish the mechanism, we first addressed the im­
portance of phosphorylation in the N terminus of cyclin B1. 
We  compared  the  nuclear  import  in  prophase  of  wild­type   
cyclin B1 with mutants carrying mutations to Ala in the auto­
phosphorylation sites (Ser126 and 128), the consensus Plk1   
site (Ser133), the NES (Ser147), or in all sites together (Ser116, 
126, 128, 133, and 147). We first determined that the rate of 
cyclin B1–GFP import was not affected by the level of its 
expression (Fig. S2). When coexpressed in HeLa cells, the 
nuclear import in prophase of all the cyclin B1 mutants linked 
Figure 3.  Active cyclin B1–Cdk1 kinase is located both in the cytoplasm and nucleus during prophase. HeLa cells coexpressing cytoplasmic and nuclear 
targeted cyclin B1–Cdk1 biosensors (fused to an NES and histone H2B, respectively) were recorded as cells entered mitosis (one image every 1 min 40 s).   
DIC (top), YFP emission (inverted grayscale; middle), and emission ratio (bottom) images are shown. Quantifications of the emission ratio in the whole cell,   
the nucleus, and the cytoplasm correspond to the cell displayed. Bar, 10 µm.JCB • VOLUME 189 • NUMBER 2 • 2010   252
and  5xE  cyclin  B1  on  optical  sections  of  cells  progressing 
from G2 phase to mitosis (Fig. 5 B). Wild­type cyclin B1   
changed from approximately five times more concentrated 
in the cytoplasm in late G2 phase to about two times more con­
centrated in the nucleus just before NEBD (cytoplasm/nucleus,   
0.4 ± 0.06; n = 6; Fig. 5 B, left). Thus, the cytoplasm still 
contained substantial levels of cyclin B1 at the end of pro­
phase. Notably, the 5xE mutant cyclin B1 reached the same 
distribution just before NEBD (cytoplasm/nucleus, 0.45 ± 
0.07; n = 5; Fig. 5 B, right). Thus, we conclude that phosphory­
lation of the N­terminal region of cyclin B1 modulates its in­
teraction with the import machinery, but this effect is only 
significant in interphase.
Cyclin B1–Cdk1 activation stimulates its 
nuclear import rate
A previous study had reported that the nuclear accumulation 
of cyclin B1 was driven by phosphorylation in the NES at 
Ser147, inhibiting its nuclear export (Toyoshima­Morimoto 
et al., 2001). Therefore, we tested whether substituting Ser147 
with glutamic acid inhibited cyclin B1 export at prophase. We 
added a Cdk inhibitor, as wild­type or the 5xE mutant cyclin B1 
began to accumulate in the nucleus in prophase and observed 
that both forms of cyclin B1 were rapidly reexported and re­
turned to the original equilibrium distribution with the same 
timing, provided that at the beginning of the experiment they 
had accumulated in the nucleus to a similar extent (Fig. 6 B, 
left). Wild­type cyclin B1 was exported more rapidly if its 
relative accumulation in the nucleus was higher than the 5xE 
mutant at the end of prophase (Fig. 6 B, right; and Video 6). 
Thus, the introduction of glutamic acids into the N terminus 
of cyclin B1 did not inhibit its nuclear export.
To  determine  whether  cyclin  B1–Cdk1  activation  in 
prophase stimulated its nuclear import, inhibited its export, 
or both, we inhibited the Crm1 exportin with leptomycin B 
(LMB). In agreement with our previous results (Hagting et al., 
1999), LMB induced a slow and progressive nuclear accumu­
lation of wild­type cyclin B1 in G2 phase cells (Fig. 7 and 
Fig. S4), whereas under the same conditions, the 5xE mutant 
was imported about five times faster than wild type. This ex­
plained the difference observed in their relative nuclear/cyto­
plasmic ratios in interphase (Fig. 5 A). However, when cells 
treated with LMB reached prophase, the nuclear import rate 
of both wild­type and 5xE cyclin B1 suddenly increased by 
up to 40­fold (Fig. 7 and Fig. S4). The timing, rate, and extent 
of nuclear accumulation of cyclin B1 during prophase were   
very similar in the presence or absence of LMB (control cells, 
n = 26: increase in rate, 20–54­fold; mean, 38­fold; LMB­
treated cells, n = 9: increase in rate, 24–55­fold; mean, 39­fold; 
Fig. S4). Thus, the nuclear accumulation of cyclin B1 in pro­
phase is almost exclusively caused by a strong stimulation of 
its import rate.
Cyclin B1–Cdk1 activation regulates the 
nuclear transport machinery
Because the rapid rise in nuclear import of cyclin B1 in prophase 
was not caused by Plk1 or by phosphorylation of cyclin B1, 
(Hagting et al., 1999; Yang et al., 2001). Therefore, we com­
pared the behavior of these mutants with wild­type cyclin B1 
through the cell cycle. First, we quantified optical sections 
obtained with a spinning­disk confocal microscope to measure 
their  distribution  between  the  cytoplasm  and  the  nucleus  in 
interphase. This showed that substitution with glutamic acids 
progressively  displaced  the  equilibrium  toward  the  nucleus, 
whereas replacing the Ser with Ala shifted the equilibrium to­
ward the cytoplasm (Fig. 5 A).
Next, we measured the change in distribution between 
the cytoplasm and nucleus of 5xE and wild­type cyclin B1 
during prophase (Fig. 6 A). We observed that the timing and 
rate of nuclear accumulation were the same, although the 
degree of nuclear accumulation of the 5xE mutant was only 
60% of wild­type cyclin B1 (n = 11; Fig. 6 A). This might 
be a direct consequence of the difference in their equilibrium 
distribution between the cytoplasm and the nucleus in inter­
phase (Fig. 5 A). Therefore, we measured the changes in the 
distribution between the cytoplasm and nucleus of wild­type 
Figure 4.  Nuclear accumulation of cyclin B1 in prophase is independent   
of its phosphorylation and of Plk1 activity. (A) Cells coexpressing wild-type 
(WT) cyclin B1–mCherry and 5xA (Ser116, 126,128,133, and 147A)– 
cyclin B1–GFP were assayed, and the nuclear accumulation of the pro-
teins was quantified. Mean curves of quantifications in different cells are 
displayed (n = 5). (B) Cells expressing wild-type cyclin B1–mCherry were 
assayed, and100 nM Plk1 inhibitor (BI 2536) was added during the 
nuclear import of cyclin B1 in prophase. Two examples are displayed 
(one image/minute). Error bars show SEM.253 Cyclin B1–Cdk1 synchronizes the nucleus and the cytoplasm • Gavet and Pines
before NEBD; M9, 24 ± 3 min before NEBD; n = 6; Fig. 8 B  
and Video 8).
To confirm that the nuclear import of cyclin B1 was not 
caused by passive diffusion after partial disassembly of nuclear 
pores  or  rupture  of  the  nuclear  envelope,  we  coexpressed 
wild­type cyclin B1–GFP (cyclin B1–Cdk1–GFP complex, mo­
lecular weight of 100) with mCherry–­tubulin (mCherry­–
­tubulin complex, molecular weight of 120) and recorded 
their nuclear accumulation by spinning­disk confocal micros­
copy. We  observed  that  in  a  similar  manner  to  IBB­GFP, 
mCherry–­tubulin began to move into the nucleus 10 min 
before NEBD, whereas cyclin B1 started to be imported several 
minutes  before  this  (cyclin  B1,  mean  of  24  ±  4  min  before 
NEBD; ­tubulin, average of 6 ± 2 min before NEBD; n = 10; 
Fig. 9 A and Video 9). Thus, our results strongly indicate that 
cyclin B1–Cdk1 activity alters the nuclear transport machinery 
early in prophase, possibly through the modification of func­
tional properties of nuclear pores, thereby triggering the nuclear 
import of cyclin B1.
Cdc25C is not imported in the nucleus 
until late prophase
Because we had evidence that the nuclear transport machin­
ery might be altered when cyclin B1–Cdk1 was activated, 
we tested whether this might alter the nuclear/cytoplasmic 
distribution  of  other  mitotic  regulators.  In  particular,  we 
assayed  the  intracellular  localization  of  Cdc25C  because 
it  had  previously  been  reported  to  move  into  the  nucleus 
in prophase (Toyoshima­Morimoto et al., 2002). We coex­
pressed  cyclin  B1–mCherry  with  GFP­Cdc25C  (Karlsson 
et  al.,  1999)  and  assayed  their  intracellular  localization 
during  prophase.  We  observed  that  the  behavior  of  GFP­
Cdc25C was indistinguishable from mCherry–­tubulin or 
we first investigated whether active cyclin B1–Cdk1 altered 
soluble import factors in prophase. Cyclin B1 binds directly to 
the N terminus of importin 1 (residues 1–462; Moore et al.,   
1999), and this domain contains a unique S/T­P sequence (Ser12) 
that is phosphorylated in mitotic cell extracts (Dephoure et al., 
2008). Therefore, we asked whether this phosphorylation might 
induce the nuclear import of cyclin B1–Cdk1, but overexpress­
ing wild­type importin 1 or mutants with this site changed to 
Ala or Glu did not alter the nuclear/cytoplasmic distribution of 
cyclin B1 in interphase (Fig. S5).
Several proteins of the nuclear pore complex are phos­
phorylated  by  cyclin  B1–Cdk1  (Macaulay  et  al.,  1995; 
Blethrow et al., 2008; for review see Kutay and Hetzer, 2008), 
making us consider the possibility that active cyclin B1–Cdk1 
might modify the permeability (i.e., size exclusion limit) and/or 
functional properties of the nuclear pores. To assay this, we 
used two different markers: an importin 1–binding domain 
of importin  (IBB) and a Gly­rich sequence recognized by 
importin 2 (M9), both fused to GFP (Lénárt et al., 2003). 
We coexpressed IBB­GFP or GFP­M9 with wild­type cyclin B1– 
mCherry, assayed their localization by spinning­disk con­
focal microscopy, and quantified optical sections of cells as 
they entered mitosis. As shown in Fig. 8 A, IBB­GFP began 
to move into the cytoplasm in late prophase 10 min before 
NEBD, most likely reflecting the increase in the size exclusion 
limit of nuclear pores (Lénárt et al., 2003), whereas cyclin B1 
started to accumulate in the nucleus several minutes before this 
(cyclin B1, mean of 21 ± 5 min before NEBD; IBB, mean of 
10 ± 1.5 min; n = 7; Video 7). Surprisingly, we observed a very 
similar timing between cyclin B1 accumulation in the nucleus 
and GFP­M9 export to the cytoplasm, although on average, 
cyclin B1 began to accumulate in the nucleus 3 min before 
M9 began to move out (cyclin B1, mean of 26.5 ± 2 min   
Figure  5.  The  nuclear/cytoplasmic  distribu-
tion of cyclin B1 is only affected by phosphor-
ylation in its N terminus domain in interphase. 
(A) The nuclear/cytoplasmic ratio of wild-type 
(WT)  cyclin  B1–GFP,  Ser126–  and  128A– 
cyclin B1–GFP, Ser126–,128A–, and 133A–
cyclin B1–GFP, 5xA (Ser116,126,128,133, and 
147A)–cyclin  B1–GFP,  Ser126–  and  128E– 
cyclin B1–GFP, Ser126–,128A–, and 133E– 
cyclin  B1–GFP,  and  5xE  (Ser116,126,128,133, 
and 147E) cyclin B1–GFP was quantified on   
optical  sections  of  asynchronous  interphase 
HeLa cells. Mean values ± SEM and numbers 
of cells assayed are displayed. (B) Cells ex-
pressing either wild-type or 5xE cyclin B1–GFP 
were  recorded.  Real  time  changes  in  the 
nuclear/cytoplasmic ratio were quantified on 
optical sections as cells entered mitosis. Five 
examples are displayed for each experiment.JCB • VOLUME 189 • NUMBER 2 • 2010   254
Cyclin B1–Cdk1 is first activated  
in the cytoplasm
One strong implication of our work is that cyclin B1–Cdk1 
must first be activated in the cytoplasm and not the nucleus in 
mammalian cells. Were it to be activated only in the nucleus, 
IBB­GFP and that the protein started to be imported in the 
nucleus in late prophase (Cdc25C, mean of 8.5 ± 2 min be­
fore NEBD; compare with cyclin B1, average of 23 ± 4 min 
before NEBD; n = 9; Fig. 9 B and Video 10). Similar results 
were obtained with Cdc25C­GFP (unpublished data). Thus, 
Cdc25C enters the nucleus several minutes after cyclin B1, 
probably as a consequence of the increase in permeability as 
nuclear pores disassemble (Lénárt and Ellenberg, 2003).
Discussion
In this study, we have used a biosensor specific for cyclin B1– 
Cdk1 to show that as soon as it is activated, cyclin B1–Cdk1   
immediately triggers its nuclear import, making this an excel­
lent surrogate marker for cyclin B1 activation. Moreover, as an 
inherent characteristic of its activation, cyclin B1–Cdk1 kinase 
can coordinate changes in the architecture of the cell in both 
compartments as cells enter mitosis (Fig. 10). The rapid nuclear 
accumulation of cyclin B1–Cdk1 in prophase can be achieved 
exclusively by a change in its rate of import and regardless of 
whether Plk1 is active. Moreover, import in prophase appears 
to be caused by a change in the nuclear transport machinery 
rather than modification of the N terminus of cyclin B1 itself. 
This change in the nuclear transport machinery eventually 
changes the equilibrium between nuclear and cytoplasmic 
cyclin B1 such that it is consistently 2:1 just before NEBD.
Figure 6.  The nuclear accumulation of wild-
type and 5xE mutant of cyclin B1 in prophase 
is concurrent. (A) The nuclear accumulation of 
cyclin B1 in prophase was assayed in cells co-
expressing wild-type (WT) cyclin B1–mCherry 
and 5xE cyclin B1–GFP. DIC (top), mCherry   
(middle), and GFP (bottom) images are shown. 
The region of interest used for quantification of 
the nuclear signal is displayed. Mean curves 
of quantifications in different cells are displayed 
(n = 6). Bar, 10 µm. (B) Cells were assayed 
as in A, and 300 nM Cdk inhibitor (Cdk1/2 
inhibitor III) was added during prophase. Two 
examples are displayed. Error bars show SEM.
Figure 7.  Cyclin B1 nuclear import rate increases significantly at mitotic 
entry. Cells expressing either wild-type (WT) or 5xE cyclin B1–GFP were 
recorded, and the nuclear import of wild-type and 5xE cyclin B1 were 
quantified after treating G2 phase cells with 20 nM LMB to inhibit nuclear 
export. Note the sudden and strong increase of the wild-type cyclin B1 
nuclear import rate when the cell enters mitosis.255 Cyclin B1–Cdk1 synchronizes the nucleus and the cytoplasm • Gavet and Pines
that inhibiting cyclin B1–Cdk1 specifically in the nucleus 
or blocking its nuclear import could generate a cell in which 
cyclin B1–Cdk1 is only active in the cytoplasm. Three ways 
by which this has been reported to happen are (1) through 
activating the Chfr tumor suppressor, (2) overexpressing Wee1   
in human cells, and (3) when the Grapes/Chk1 kinase is activated 
in Drosophila melanogaster syncitial embryos (Heald et al., 1993; 
Summers et al., 2005; Royou et al., 2008). Our results tend to 
preclude all three mechanisms.
(1) In the study on the effect of Chfr, cyclin B1–Cdk1 itself 
was not activated (Summers et al., 2005), and our results now 
show that there is, therefore, no need to postulate an extra effect 
on cyclin B1 import because activation and import are coupled. 
(2) We have measured the effect of overexpressing Wee1 using 
targeted FRET biosensors to monitor cyclin B1–Cdk1 activity in 
the nucleus and the cytoplasm but find that we cannot uncouple 
the activities in the two compartments, which is the result pre­
dicted by our finding that active cytoplasmic cyclin B1–Cdk1 en­
hances its nuclear import and that nuclear export is not inhibited 
during prophase. (3) A similar argument applies to the effect of 
Chk1, at least in human cells. Thus, at present, we have found no 
it is difficult to see how any cyclin B1–Cdk1 activity could reach   
the  cytoplasm  until  NEBD  because  activation  induces  an 
40­fold increase in the rate of cyclin B1–Cdk1 nuclear import. 
In agreement with this, we observed that cytoplasmic events   
such as cell rounding and centrosome separation follow almost 
immediately after, and remain dependent on, cyclin B1–Cdk1 
activation (Gavet and Pines, 2010). Moreover, the nuclear ac­
cumulation of cyclin B1 is not affected by inhibiting its export.   
In further support of this conclusion, antiphospho antibodies that   
only recognize active cyclin B1–Cdk1 first stain centrosomes 
in mammalian cells (Jackman et al., 2003), and cyclin B1–
Cdk1 can be activated in the absence of nuclei in X. laevis 
oocytes (Hara et al., 1980; Pérez­Mongiovi et al., 2000). Thus, 
activation in the cytoplasm allied with the immediate and rapid 
nuclear import of a proportion but not all of cyclin B1–Cdk1 
means that activating cyclin B1–Cdk1 inherently synchronizes 
mitotic events in the cytoplasm and nucleus.
Our finding that cyclin B1–Cdk1 nuclear import remains de­
pendent on cyclin B1–Cdk1 activity until NEBD also means that   
any enzyme repressing its activity, such as Chk1, Wee1, or Myt1, 
would also prevent cyclin B1–Cdk1 import. It has been suggested 
Figure  8.  The  nuclear  accumulation  of  cy-
clin  B1–Cdk1  in  prophase  correlates  with 
a  change  in  nuclear  transport  machinery.  
(A and B) Cells coexpressing cyclin B1–mCherry 
and IBB-GFP (A) or GFP-M9 (B) were recorded 
as they entered mitosis (one image/30 s), and 
the import of cyclin B1 and export of IBB or 
M9  quantified  on  optical  sections.  (A)  The 
mCherry (top) and GFP (bottom) images and   
mean curves of quantification of nuclear cy-
clin  B1  and  cytoplasmic  IBB  are  shown.   
(B) mCherry (top), GFP (middle), and pseudo-
colored  GFP  (rainbow  look  up  table  [LUT]; 
bottom) images and mean curves of quantifi-
cation of the nuclear cyclin B1 and cytoplas-
mic M9 are displayed. Boxed images show 
the time point when cyclin B1 begins to enter 
the nucleus and GFP-M9 begins to exit. Error 
bars show SEM. Bars, 10 µm.JCB • VOLUME 189 • NUMBER 2 • 2010   256
either triggers or is essential for the accumulation of cyclin B1 
in the nucleus. But, in direct contradiction to this and in agree­
ment with our previous conclusions (Jackman et al., 2003) and 
those of others (Lénárt et al., 2007), we have shown in this 
study that neither Plk1 activity nor the inhibition of nuclear 
export is required for the rapid accumulation of cyclin B1–
Cdk1 in prophase. Indeed, we find no evidence that altering 
nuclear export rates contributes to the nuclear accumulation 
evidence that the nuclear import of cyclin B1 per se is subject to 
regulation aside from the controls on the activation of cyclin B1– 
Cdk1, nor is there any need to invoke such regulation.
Plk1 acts upstream of the nuclear import 
of cyclin B1–Cdk1
A prevailing idea concerning mitotic entry is that by phosphory­
lating cyclin B1 to block its nuclear export, the Plk1 kinase 
Figure 9.  Cyclin B1 but not Cdc25C moves 
into the nucleus before the nuclear pores be-
come permeable to tubulin. (A and B) Cells 
coexpressing cyclin B1–GFP and mCherry–
-tubulin (A) or cyclin B1–mCherry and GFP-
Cdc25C  (B)  were  recorded  as  they  entered 
mitosis (one image/40 s and one image/30 s, 
respectively),  and  the  import  of  cyclin  B1, 
-tubulin, and Cdc25C was quantified on op-
tical sections. (A) The GFP (top) and mCherry 
(bottom) images and mean curves of quantifi-
cation of nuclear cyclin B1 and -tubulin are 
shown.  (B)  mCherry  (top)  and  GFP  (bottom) 
images and mean curves of quantification of 
the  nuclear  cyclin  B1  and  Cdc25C  are  dis-
played. Error bars show SEM. Bars, 10 µm.
Figure  10.  Model  showing  how  activating   
cyclin B1–Cdk1 synchronizes the cytoplasm with 
the nucleus. The activation (1) of cyclin B1– 
Cdk1  kinase  synchronizes  cytoplasmic  (left) 
and  nuclear  (right)  events  through  trigger-
ing its own nuclear import (2) by modifying 
nuclear import adapters, the functional prop-
erties of nuclear pores, or both.257 Cyclin B1–Cdk1 synchronizes the nucleus and the cytoplasm • Gavet and Pines
that Cdc25C is necessary to keep cyclin B1–Cdk1 active in the 
nucleus (Toyoshima­Morimoto et al., 2002), which was also 
somewhat at odds with the finding that Cdc25C is not essen­
tial in mice (Chen et al., 2001). We previously observed that 
Plk1 is imported in the nucleus at almost the same time as 
cyclin B1–Cdk1 when expressed in G2 phase cells, possibly 
through a modification of the nuclear transport machinery by 
active cyclin B1–Cdk1 (Jackman et al., 2003). However, when 
Plk1 is expressed earlier during the cell cycle, it equilibrates   
between the cytoplasm and the nucleus, and in these conditions, 
we do not observe a reproducible and significant import of 
Plk1 in the nucleus (unpublished data). Thus, at present, we do 
not have any strong evidence that the activation of cyclin B1– 
Cdk1 requires a change in the nuclear/cytoplasmic distribu­
tion of its upstream regulators.
We conclude that the rapid change in the nuclear import 
machinery that immediately follows cyclin B1–Cdk1 activation 
is intrinsic to how cytoplasmic and nuclear events are coordinated 
at mitosis. Determining the substrates modified by cyclin B1–




LMB and Cdk1/2 inhibitor III (5-amino-3-((4-(aminosulfonyl) phenyl) amino)-
N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide)  were  purchased 
from Merck Biosciences. RO3306 (Vassilev et al., 2006) was provided by   
L. Vassilev (Roche) and A. Giannis (University of Leipzig, Leipzig, Germany). 
BI  2536  was  purchased  from  Axon  Medchem.  ZM  447439  was  pro-
vided by N. Keen (AstraZeneca).
Cell culture and synchronization
HeLa cells were cultured in advanced DME (Invitrogen) supplemented 
with 2% FBS (Invitrogen), 200 µM Glutamax-1, 100 U/ml penicillin, 
100  µg/ml  streptomycin,  and  250  ng/ml  fungizone  at  37°C  with 
10% CO2. For time-lapse imaging, cells were cultured on glass-bottom 
dishes  (Willco  Wells)  precoated  with  fibronectin  (Sigma-Aldrich)  at   
1  µg/cm
2  for  2  h  before  use.  Cells  were  synchronized  in  S  phase 
by addition of 2.5 mM thymidine for 24 h then released into fresh 
medium. Cells entered mitosis on average 12 h after release from the 
thymidine block.
Transfection
HeLa cells were electroporated (3 × 10
6 cells; 10–20 µg DNA) at 250 V 
and 1,500 µF in 4-mm cuvettes using an electroporator (Easyject plus; 
Equibio). We estimated the transfection efficiency to be 40–60% de-
pending on the quality of DNA. Cells were immediately plated on coated 
glass-bottom dishes and synchronized 7 h after transfection by a thymi-
dine block and release. Alternatively, asynchronous cells were recorded 
24 h after transfection.
Time-lapse imaging
Time-lapse imaging was performed on cells in L15 medium with 10% serum 
at 37°C using either an epifluorescence microscope (Deltavision; Applied 
Precision)  controlled  by  SoftWoRx  software  and  equipped  with  an  in-
verted microscope (IX70; Olympus), an electron multiplier charge-coupled 
device camera (Cascade II 512K; Photometrics), and a 40× UApo NA 
1.35 objective (Olympus) or a spinning-disk system (Marianas; Intelligent 
Imaging Innovations) controlled by Slidebook software and comprising 
a microscope (Axiovert Observer Z1; Carl Zeiss, Inc.) equipped with a 
disk-scanning unit (CSU-X1 Nipkow; Yokogawa) and a camera (QuantEM 
512SC; Yokogawa). FRET imaging was performed using a CFP/YFP filter 
set with CFPex 436/10, CFPem 470/30, YFPem 535/30, and a CFP/
YFP/mCherry dichroic C85363 (Chroma Technology Corp.). The same 
exposure time was used for CFPex/CFPem and CFPex/YFPem (between 
100 and 200 ms). All quantifications were performed using ImageJ software 
of cyclin B1–Cdk1. Instead, this can be entirely generated 
through an up to 40­fold increase in its import rate. Because 
the rate of import is the same in the presence or absence of 
Plk1 activity but fewer cells enter mitosis in the absence of Plk1 
(Gavet and Pines, 2010), our experiments indicate that Plk1 
acts upstream of cyclin B1–Cdk1 nuclear import.
Phosphorylation of B1 alters its import 
rate but is only significant in interphase
Our earlier experiments indicated that substituting five con­
served Ser in the N terminus of cyclin B1 with Ala appeared 
to prevent the protein from entering the nucleus until NEBD, 
whereas substituting them for glutamic acid created a nuclear 
import signal (Hagting et al., 1999). Since then, however, the 
development of highly sensitive charge­coupled device cam­
eras  and  spinning­disk  confocal  microscopy  have  improved 
our ability to assay and quantify the beginning of cyclin B1 
nuclear entry, and we now show that both the wild­type and 
the Ala mutants are imported much earlier (20 min before 
NEBD) than we had previously thought. We have confirmed 
that glutamic acid substitutions do cause cyclin B1 to become 
more nuclear in interphase because they increase its rate of 
import by about fivefold. However, this does not significantly 
contribute to the 40­fold increase in the import rate once 
cells activate cyclin B1–Cdk1. Thus, the phosphorylation of 
cyclin B1 might help its nuclear import but is not necessary 
at prophase.
There is a general change in the nuclear 
transport machinery at prophase
One clue to the mechanism by which cyclin B1 is imported 
rapidly in prophase might be that at almost exactly the same 
time that cyclin B1 begins to accumulate in the nucleus, the 
M9 domain, which binds to transportin/importin 2, starts to 
become cytoplasmic. Thus, it is possible that modification of 
nuclear pore complexes and/or soluble receptors in prophase   
by active cyclin B1–Cdk1 alters the nuclear/cytoplasmic equilib­
rium of different proteins at the same time (Onischenko et al., 
2005; Mühlhäusser and Kutay, 2007). Although importin 1   
has a conserved Cdk consensus site in the region that binds 
to cyclin B1, overexpression of wild­type importin 1 or 
phosphorylation site mutants did not alter the nuclear/cyto­
plasmic  distribution  of  cyclin  B1.  Unfortunately,  the  nucleo­
porins  have  a  plethora  of  consensus  Cdk1  sites  that  are 
phosphorylated at mitosis, making the task of identifying the 
proteins and crucial residues responsible extremely arduous 
(Blethrow et al., 2008; Dephoure et al., 2008; for review see 
Kutay and Hetzer, 2008). The driving force behind the rapid 
import of cyclin B1 is also unclear. One possibility is that the 
driving  force  might  be  generated  by  the  existing  nuclear/
cytoplasmic gradient allied to cyclin B1–Cdk1 binding with 
condensed chromatin (Clute and Pines, 1999; Jackman et al., 
2003; unpublished data).
In contrast to previous findings, we found that the nuclear 
accumulation of cyclin B1–Cdk1 kinase is not accompanied 
by the import of its activator, Cdc25C (Toyoshima­Morimoto 
et al., 2002). Thus, our experiments do not support the idea JCB • VOLUME 189 • NUMBER 2 • 2010   258
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(National  Institutes  of  Health).  For  emission  ratio  measurements,  we 
used the following formulas: whole cell signal = sum of the intensity 
of the pixels for one cell; mean background signal = mean signal per 
pixel for a region selected just beside the cell; whole cell signal cor-
rected = whole cell signal  (area for the selected cell × mean back-
ground); and emission ratio = whole cell YFP signal corrected/whole 
cell CFP signal corrected.
Intensity-modulated display representations were performed using 
MetaMorph software according to the manufacturer’s recommendations 
(MDS Analytical Technologies). In brief, for each intensity-modulated dis-
play, we used eight color hues and 32 intensities, ranking from dark to 
bright per hue. The maximum and minimum values were fixed manually 
and are indicated on each figure. The color intensities displayed for each 
hue were determined automatically by the software using one of the   
CFPex/YFPem images as a reference (Tsien and Harootunian, 1990).
For quantifications of cytoplasmic/nuclear ratio, we designed a re-
gion of interest corresponding approximately to one third of the nucleus 
and excluding centrosomes (Fig. 6 A) that could be used to quantify the nu-
clear signal and the cytoplasmic signal close to the nucleus in the same 
cell. FRAP experiments were performed using a 488-nm laser at maximum 
power and an exposure time of 100 ms.
Constructs
FRET biosensor. Cerulean containing the monomeric mutation A207K (pro-
vided by D. Piston, Vanderbilt University, Brentwood, TN; Rizzo et al., 
2004) was linked to YPet (provided by P. Daugherty, University of Califor-
nia, Santa Barbara, Santa Barbara, CA; Nguyen and Daugherty, 2005) 
with the minimal domain of the Polo-like kinase 1 polo box (residues 373–
592) that is sufficient for binding to phospho-Ser/Thr residues (Cheng et al., 
2003; Elia et al., 2003) plus 16 amino acids from the autophosphory-
lation site of human cyclin B1 with the Ala at the 1 position (underlined) 
altered to Ser (PEPILVDT-S-pS126-P-pS128-P-MET).
Homo sapiens cyclin B1–mCherry. mCherry (NCBI Protein database 
accession no. ACF75945.1) was amplified by PCR and used to replace 
the AgeI–NotI fragment containing ECFP in pECFP–cyclin B1. Wild-type 
and mutated forms of H. sapiens cyclin B1 fused to GFP have been previ-
ously described (Hagting et al., 1999). pIBB-GFP and pGFP-M9 (Lénárt 
et al., 2003) were provided by P. Lénárt (European Molecular Biology 
Laboratory, Heidelberg, Germany).
pWT–, Ser12A–, or Ser12E–importin 1 IRES2-GFP. Full-length importin 1 
coding sequence was amplified by PCR using mutagenesis primers and 
subcloned as a SacII–BamHI fragment in pIRES2-GFP (Takara Bio Inc.). 
GFP-Cdc25C has been previously described (Karlsson et al., 1999).
Online supplemental material
Fig. S1 shows that the nuclear targeted FRET sensor is stably associated 
with chromatin. Fig. S2 shows that kinetics of cyclin B1 nuclear accumu-
lation is independent of the expression level. Fig. S3 shows that nuclear 
accumulation of cyclin B1 in prophase is independent of its phosphory-
lation on Ser126, 128, 133, and 147. Fig. S4 shows that cyclin B1 
nuclear import rate increases significantly at mitotic entry. Fig. S5 shows 
that the nuclear/cytoplasmic distribution of cyclin B1 in interphase is not 
affected by overexpression of wild-type or phosphorylation mutants of 
importin 1.
Video 1 shows a HeLa cell expressing FRET sensor and cyclin B1 
entering mitosis. Video 2 shows a HeLa cell expressing FRET sensor and 
cyclin B1 treated with a Cdk inhibitor during prophase. Video 3 shows 
a HeLa cell expressing FRET sensor targeted to both the nucleus and the 
cytoplasm undergoing mitosis. Video 4 shows a HeLa cell expressing the 
5xA Ala mutant and wild-type cyclin B1 entering mitosis. Video 5 shows 
a HeLa cell expressing wild-type cyclin B1 entering mitosis and treated 
with the Plk inhibitor BI 2536. Video 6 shows a HeLa cell expressing the 
5xE glutamic acid mutant and wild-type cyclin B1 entering mitosis and 
treated with a Cdk inhibitor. Video 7 shows a HeLa cell expressing wild-
type cyclin B1–mCherry and IBB-GFP entering mitosis. Video 8 shows a 
HeLa cell expressing wild-type cyclin B1–mCherry and GFP-M9 entering 
mitosis. Video 9 shows a HeLa cell expressing wild-type cyclin B1–GFP 
and mCherry–-tubulin (right) entering mitosis. Video 10 shows a HeLa 
cell expressing wild-type cyclin B1–mCherry and GFP-Cdc25C entering   
mitosis. Additional supplemental data shows DNA sequences used in this 
study. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.200909144/DC1.
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